Cargando…
Senicapoc treatment in COVID‐19 patients with severe respiratory insufficiency—A randomized, open‐label, phase II trial
BACKGROUND: The aim of the current study was to determine if treatment with senicapoc, improves the PaO(2)/FiO(2) ratio in patients with COVID‐19 and severe respiratory insufficiency. METHODS: Investigator‐initiated, randomized, open‐label, phase II trial in four intensive care units (ICU) in Denmar...
Autores principales: | Granfeldt, Asger, Andersen, Lars W., Vallentin, Mikael F., Hilberg, Ole, Hasselstrøm, Jørgen B., Sørensen, Lambert K., Mogensen, Susie, Christensen, Steffen, Grejs, Anders M., Rasmussen, Bodil S., Kristiansen, Klaus T., Strøm, Thomas, Johansen, Isik S., Schjørring, Olav L., Simonsen, Ulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111301/ https://www.ncbi.nlm.nih.gov/pubmed/35403225 http://dx.doi.org/10.1111/aas.14072 |
Ejemplares similares
-
A validated UHPLC-MS/MS method for rapid determination of senicapoc in plasma samples
por: Sørensen, Lambert K., et al.
Publicado: (2021) -
Treatment with senicapoc in a porcine model of acute respiratory distress syndrome
por: Petersen, Asbjørn G., et al.
Publicado: (2021) -
Effect of the KCa3.1 blocker, senicapoc, on cerebral edema and cardiovascular function after cardiac arrest — A randomized experimental rat study
por: Hansen, Frederik Boe, et al.
Publicado: (2021) -
Respiratory and circulatory insufficiency during emergent long-distance critical care interhospital transports to tertiary care in a sparsely populated region: a retrospective analysis of late mortality risk
por: Fredriksson Sundbom, Marcus, et al.
Publicado: (2022) -
Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation—the protocol of the prospective cohort BIONEC study
por: Hansen, Marco Bo, et al.
Publicado: (2015)